Attached files
file | filename |
---|---|
EX-99.2 - EX-99.2 - BODY & MIND INC. | bmmj_ex992.htm |
EX-99.1 - EX-99.1 - BODY & MIND INC. | bmmj_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
August 15, 2018
Date of Report (Date of earliest event reported)
BODY AND MIND INC. |
(Exact name of registrant as specified in its charter) |
Nevada |
| 000-55940 |
| 98-1319227 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
750 – 1095 West Pender Street |
| V6E 2M6 |
(Address of principal executive offices) |
| (Zip Code) |
(604) 376-3567
Registrant’s telephone number, including area code
Not applicable.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x
Item 7.01 Regulation FD Disclosure
On September 19, 2018, Body and Mind Inc. (the “Company”) issued a news release announcing that the Company, through its subsidiary, Nevada Medical Group LLC (“NMG”), and its strategic in-state investment partners received notification that the State of Ohio awarded a medical cannabis production license to NMG Ohio, LLC (“NMG Ohio”). The Company’s subsidiary, NMG, currently maintains a 30% ownership interest in NMG Ohio.
A copy of the news release is attached as Exhibit 99.1 hereto.
Item 8.01 Other Events
On August 15, 2018, the Company issued a news release announcing the completion of its Phase II cultivation expansion on its facility located in Las Vegas, Nevada, and that cultivation has commenced in the newly renovated areas and has provided the Company with enough operation spade to add approximately 40% additional high pressure sodium lights to its facility.
A copy of the news release is attached as Exhibit 99.2 hereto.
Item 9.01 Financial Statements and Exhibits
(a) Financial Statements of Business Acquired
Not applicable.
(b) Pro forma Financial Information
Not applicable.
(c) Shell Company Transaction
Not applicable.
(d) Exhibits
Exhibit |
| Description |
|
|
|
| ||
|
|
|
|
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BODY AND MIND INC. | |||
DATE: September 19, 2018 | By: | /s/ Darren Tindale | |
|
| Darren Tindale | |
Chief Financial Officer |
3 |